ClinicalTrials.gg
RecruitingNCT05848895OPT-INUpdated Aug 3, 2025

OPT-IN: Osteopathic Plagiocephaly Treatment for Infants and Neonates

An interventional study of Osteopathic Manipulative Treatment and Standard of Care Repositioning in Plagiocephaly, Nonsynostotic, Plagiocephaly, Positional and Plagiocephaly, sponsored by Osteopathy's Promise to Children. Recruiting at 1 site in United States. Open to participants aged 1 Day to 4 Months. Per ClinicalTrials.gov, last updated 2025-08-03.

Sponsored by Osteopathy's Promise to Children · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Oct 2023; still recruiting 3 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
122
Allocation
Randomized
Ages
1 Day to 4 Months
Sex
All
01

Study summary

The goal of this crossover randomized clinical trial is to assess the effects of osteopathic manipulative treatment (OMT) compared to standard of care repositioning in children diagnosed with positional/deformational plagiocephaly. The main hypothesis is that children who received OMT will show significantly improved anthropometric measures of cranial symmetry over those receiving the current pediatric standard of care of repositioning.

This is a two-arm, randomized cross-over clinical trial. With parental consent, pediatric patients (infants \<4 months of age) will be organized into one of two groups:

  1. Those who receive OMT with emphasis on osteopathic cranial manipulative medicine (OCMM) to restore cranial symmetry.
  2. Those who receive standard care only with repositioning attention from the parents After 8-weeks of being in the first group, each participant will cross-over into the second group (OMT or repositioning) N = 122 subjects diagnosed with deformational plagiocephaly (DP) are to be recruited (to allow for natural attrition and loss to follow up) with the recruitment to continue until 61 patients have been placed in each of the two groups and will cross-over to the respective treatment group (OMT and standard of care repositioning therapy).

Timeline: It is projected that to recruit and carry out the assessments and interventions (8-weeks of each group with 12-months of follow-up longitudinally), it will require two years (24-months) from the beginning of the study to completion.

02

Conditions studied

  • Plagiocephaly, Nonsynostotic
  • Plagiocephaly, Positional
  • Plagiocephaly
  • Cranium; Deformity

Keywords

  • Positional Plagiocephaly
  • Nonsynostotic Plagiocephaly
  • Repositioning
  • Osteopathic Manipulative Treatment
  • Cranial asymetry
03

In context

Plagiocephaly

16 studies on the registry are indexed under Plagiocephaly; 4 are open to participants now.

Browse Plagiocephaly studies →

Lead sponsor

This is the only study on the registry with Osteopathy's Promise to Children as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 4 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with positional plagiocephaly
  • Under 4-months of age (between birth - 4 months) at the time of enrollment

Exclusion criteria

Exclusions:

  • Preterm birth (\<37 weeks)
  • Genetic syndromes
  • Craniofacial defects/deformities (e.g. cleft lip/palate)
  • Brachycephaly/scaphocephaly
  • Hypotonia
  • Hypertonia
  • Craniosynostosis
  • Head trauma or other neurological illnesses
  • Lost to follow up
  • Patient whose parents (or legal guardians) disagree to attend 8-treatments of OMT and 2 additional measurement sessions
  • Prior helmet therapy, physical therapy, or OMT before the date of enrollment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
122 participants (estimated)

Study arms

  • Experimental
    Osteopathic Manipulative Treatment

    Patients will be treated once a week with OMT x 8 weeks

    Procedure: Osteopathic Manipulative Treatment

  • Active comparator
    Standard of Care Repositioning

    Patients will only receive repositioning only x 8 weeks and all parents will receive standardized materials to counsel/instruct on the repositioning

    Behavioral: Standard of Care Repositioning

Interventions

  • ProcedureOsteopathic Manipulative Treatment

    Osteopathic Manipulative Treatment is a manual treatment therapy applied by licensed physicians that consists of using ones hands to improve the structure and function of the body. In this situation it will involve gentle and passive modalities that are well-tolerated by infants.

  • BehavioralStandard of Care Repositioning

    Parents will receive standardized handouts/materials instructing on repositioning intended to help improve head shape in infants with plagiocephaly.

06

What researchers measure

Primary outcomes

  1. Cranial Vault Asymmetry Index

    Anthropometric measurement of cranial asymmetry

    Time frame: 2 years

  2. Head circumference

    Standard growth parameter measured in infants

    Time frame: 2 years

  3. Weight

    Standard growth parameter measured in infants

    Time frame: 2 years

Secondary outcomes

  1. Medical history

    Patients charts will be reviewed after first year of life to assess for medical issues including otitis media, developmental delay, allergic rhinitis, vision problems, torticollis, hospitalizations, need for a helmet to treat plagiocephaly, colic, reflux/GER, etc.

    Time frame: 12 months

  2. Developmental Milestones

    Patients' enrolled in the study will have developmental stones monitored as per general pediatrician's protocol to screen for developmental delays.

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
  • Osteopathic Center San Diego
    San Diego, California 92123, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05848895
Lead sponsor
Osteopathy's Promise to Children
Responsible party
Kimberly Wolf (Kimberly Wolf, DO, Osteopathy's Promise to Children) — Principal investigator
First posted
May 8, 2023
Start date
Oct 26, 2023
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Aug 3, 2025

Study contacts

Kimberly J Wolf, DO
Contact
kimberly.wolf@the-promise.org
619-583-7611
Jessica Martone, PhD, MSW
Contact
jessica.martone@the-promise.org
619-693-6303
Kimberly J Wolf, DO
principal investigator · Osteopathy's Promise to Children

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion